Showing 1,441 - 1,460 results of 152,588 for search '(( 5 ((ng decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( a we decrease ))', query time: 1.72s Refine Results
  1. 1441
  2. 1442
  3. 1443
  4. 1444

    Neuroimaging findings. by Irene Flønes (849434)

    Published 2016
    “…C (upper lane): FDG-PET scan of the brain of patient 1 taken ~5 years later shows multiple foci of decreased glucose metabolism that correlate to the localization of the transient cortical signal changes on MRI. …”
  5. 1445

    Supplementary Material for: Optimistic Youth: Young Adults Predicted a Faster Decrease in Risk during COVID-19 Emergency State in Portugal by Scaletti S. (12434691)

    Published 2022
    “…Do these age-related differences influence risk perception during a pandemic crisis? Here, we investigated how age influenced predicted risk during the COVID-19 emergency state in Portugal. …”
  6. 1446

    Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation – A microsimulation study by Matthew A. Pappas (5504363)

    Published 2018
    “…<div><p>Background</p><p>Anticoagulation decreases a patient’s risk of ischemic stroke and increases the risk of hemorrhage. …”
  7. 1447

    Heterologous Immunity Triggered by a Single, Latent Virus in <i>Mus musculus</i>: Combined Costimulation- and Adhesion- Blockade Decrease Rejection by Jonathan M. Beus (441623)

    Published 2013
    “…<div><p>The mechanisms underlying latent-virus-mediated heterologous immunity, and subsequent transplant rejection, especially in the setting of T cell costimulation blockade, remain undetermined. To address this, we have utilized MHV68 to develop a rodent model of latent virus-induced heterologous alloimmunity. …”
  8. 1448
  9. 1449
  10. 1450
  11. 1451
  12. 1452
  13. 1453

    Panel (a) compares SO<sub>2</sub> emissions prescribed over the historical period in the CMIP5 simulations (solid grey) with three inventory-based estimates of historical emissions... by Nathan P Gillett (557010)

    Published 2013
    “…<p><strong>Figure 1.</strong> Panel (a) compares SO<sub>2</sub> emissions prescribed over the historical period in the CMIP5 simulations (solid grey) with three inventory-based estimates of historical emissions [<a href="http://iopscience.iop.org/1748-9326/8/3/034008/article#erl467068bib1" target="_blank">1</a>, <a href="http://iopscience.iop.org/1748-9326/8/3/034008/article#erl467068bib10" target="_blank">10</a>, <a href="http://iopscience.iop.org/1748-9326/8/3/034008/article#erl467068bib11" target="_blank">11</a>]. …”
  14. 1454
  15. 1455
  16. 1456
  17. 1457
  18. 1458

    A PPARα Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes by Sharon Cresci (53599)

    Published 2010
    “…Consistent with previous descriptions of PPARα in experimental models and human disease, we describe a novel <em>PPARA</em> promoter SNP that decreases transcriptional activation of <em>PPARA</em> and protects against mortality in diabetic patients after ACS.…”
  19. 1459
  20. 1460